<VariationArchive VariationID="189242" VariationName="NM_002863.5(PYGL):c.25_44dup (p.Ser15fs)" VariationType="Duplication" Accession="VCV000189242" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2015-04-01" MostRecentSubmission="2022-12-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="187131" VariationID="189242">
      <GeneList>
        <Gene Symbol="PYGL" FullName="glycogen phosphorylase L" GeneID="5836" HGNC_ID="HGNC:9725" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="50905217" stop="50944483" display_start="50905217" display_stop="50944483" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="51371934" stop="51411247" display_start="51371934" display_stop="51411247" Strand="-" />
          </Location>
          <OMIM>613741</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002863.5(PYGL):c.25_44dup (p.Ser15fs)</Name>
      <CanonicalSPDI>NC_000014.9:50944359:CTGATCTGCCGCCGCTTCTCCTG:CTGATCTGCCGCCGCTTCTCCTGATCTGCCGCCGCTTCTCCTG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>14q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="50944359" stop="50944360" display_start="50944359" display_stop="50944360" variantLength="20" positionVCF="50944359" referenceAlleleVCF="G" alternateAlleleVCF="GCTGATCTGCCGCCGCTTCTC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="51411077" stop="51411078" display_start="51411077" display_stop="51411078" variantLength="20" positionVCF="51411077" referenceAlleleVCF="G" alternateAlleleVCF="GCTGATCTGCCGCCGCTTCTC" />
      </Location>
      <OtherNameList>
        <Name>NM_002863.4:c.25_44dup</Name>
        <Name>p.Ser15ArgfsX21</Name>
      </OtherNameList>
      <ProteinChange>S15fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002863.5" sequenceAccession="NM_002863" sequenceVersion="5" change="c.25_44dup" MANESelect="true">
            <Expression>NM_002863.5:c.25_44dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002854.3" sequenceAccession="NP_002854" sequenceVersion="3" change="p.Ser15fs">
            <Expression>NP_002854.3:p.Ser15fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.51411081_51411100dup" Assembly="GRCh37">
            <Expression>NC_000014.8:g.51411081_51411100dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.50944363_50944382dup" Assembly="GRCh38">
            <Expression>NC_000014.9:g.50944363_50944382dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012796.1" sequenceAccession="NG_012796" sequenceVersion="1" change="g.5152_5171dup">
            <Expression>NG_012796.1:g.5152_5171dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001163940.2" sequenceAccession="NM_001163940" sequenceVersion="2" change="c.25_44dup">
            <Expression>NM_001163940.2:c.25_44dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157412.1" sequenceAccession="NP_001157412" sequenceVersion="1" change="p.Ser15fs">
            <Expression>NP_001157412.1:p.Ser15fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA274495" DB="ClinGen" />
        <XRef Type="rs" ID="786204785" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002863.5(PYGL):c.25_44dup (p.Ser15fs) AND Glycogen storage disease, type VI" Accession="RCV000169673" Version="5">
        <ClassifiedConditionList TraitSetID="3244">
          <ClassifiedCondition DB="MedGen" ID="C0017925">Glycogen storage disease, type VI</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2013-11-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002863.5(PYGL):c.25_44dup (p.Ser15fs) AND not provided" Accession="RCV002460948" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-04-01" MostRecentSubmission="2022-12-03">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3244" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10922" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease, type VI</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+6/3126" DB="Genetic Alliance" />
                <XRef ID="29291001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatic glycogen phosphorylase deficiency</ElementValue>
                <XRef ID="237971004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 6</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hers disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD VI</ElementValue>
                <XRef Type="MIM" ID="232700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Phosphorylase deficiency glycogen-storage disease of liver</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD6</ElementValue>
                <XRef Type="MIM" ID="232700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type VI (GSD VI) is a disorder of glycogenolysis caused by deficiency of hepatic glycogen phosphorylase. This critical enzyme catalyzes the rate-limiting step in glycogen degradation, and deficiency of the enzyme in the untreated child is characterized by hepatomegaly, poor growth, ketotic hypoglycemia, elevated hepatic transaminases, hyperlipidemia, and low prealbumin level. GSD VI is usually a relatively mild disorder that presents in infancy and childhood; rare cases of more severe disease manifesting with recurrent hypoglycemia and marked hepatomegaly have been described. More common complications in the setting of suboptimal metabolic control include short stature, delayed puberty, osteopenia, and osteoporosis. Hepatic fibrosis commonly develops in GSD VI, but cirrhosis and hypertrophic cardiomyopathy are rare. Clinical and biochemical abnormalities may decrease with age, but ketosis and hypoglycemia can continue to occur.</Attribute>
                <XRef ID="NBK5941" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6529" />
                <XRef ID="6529" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301760</ID>
                <ID Source="BookShelf">NBK5941</ID>
              </Citation>
              <XRef ID="369" DB="Orphanet" />
              <XRef ID="C0017925" DB="MedGen" />
              <XRef ID="MONDO:0009294" DB="MONDO" />
              <XRef Type="MIM" ID="232700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5391943" SubmissionDate="2022-11-29" DateLastUpdated="2022-12-03" DateCreated="2022-12-03">
        <ClinVarSubmissionID localKey="GDXSV:248670" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002757013" DateUpdated="2022-12-03" DateCreated="2022-12-03" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PYGL" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:4864732</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002863.4:c.25_44dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_143_20221123054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="399818" SubmissionDate="2015-03-06" DateLastUpdated="2015-04-01" DateCreated="2015-04-01">
        <ClinVarSubmissionID localKey="41183307|OMIM:232700" />
        <ClinVarAccession Accession="SCV000221208" DateUpdated="2015-04-01" DateCreated="2015-04-01" Type="SCV" Version="2" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-11-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The Ser15ArgfsX21 variant in PYGL has not been previously reported in individuals with glycogen storage disease 6 or in large population studies. However, this novel frameshift variant is predicted to alter the protein’s amino acid sequence beginning at position 15 and lead to a premature termination codon 21 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. This variant meets our criteria to be classified as pathogenic (http://pcpgm.partners.org/LMM) based upon the established role of loss-of-function variants in glycogen storage disease 6.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PYGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="14" alternateAllele="CTGATCTGCCGCCGCTTCTC" referenceAllele="-" start="51411077" stop="51411078" variantLength="2" />
            <GeneLocation>NM_002863.4:EXON 1</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_002863.4:c.25_44dup</Name>
            <Name>p.Ser15ArgfsX21</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.51411077_51411078insCTGATCTGCCGCCGCTTCTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Glycogen storage disease 6</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="232700" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-MedSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>MedSeq_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="399818" TraitType="Disease" MappingType="Name" MappingValue="Glycogen storage disease 6" MappingRef="Preferred">
        <MedGen CUI="C0017925" Name="Glycogen storage disease, type VI" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5391943" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

